Results 11 to 20 of about 33,094 (239)

Oral verapamil in paroxysmal supraventricular tachycardia recurrence control: a randomized clinical trial [PDF]

Therapeutic Advances in Cardiovascular Disease, 2015
Background: Adenosine is the first-line medication in patients with paroxysmal supraventricular tachycardia. Because it is cleared so rapidly from the circulation, recurrence of paroxysmal supraventricular tachycardia after initial successful conversion ...
Marzieh Fathi, Fatemeh Jahanian
exaly   +4 more sources

Paroxysmal Supraventricular Tachycardia Following Ondansentron Intravenous Administration: A Case Report [PDF]

Majalah Kardiologi Indonesia, 2015
Ondasentron is selective serotonin 5-HT3 receptor antagonist. It is widely used as the drug of choice for preventing nausea and vomiting associated with chemotheraphy and post-surgery.
Erick Hoetama
doaj   +3 more sources

Clinical Practice Guidelines for paroxysmal supraventricular tachycardia. [PDF]

Medisur, 2009
Clinical Practice Guidelines for paroxysmal supraventricular tachycardia. These are arrhythmias in which structures placed above the bifurcation of the bundle of His are involved; characterized by tachycardia with abrupt starting and ending.
Brandy Viera Valdés, Francisco De Jesús Valladares Carvajal, Félix Rolando Jorrín Román, Pablo Rodríguez Díaz   +3 more
doaj   +4 more sources

Cartap Poisoning with Paroxysmal Supraventricular Tachycardia: A Case Report [PDF]

Journal of Nepal Medical Association
Cartap, a nereistoxin derivative from the marine annelid Lumbriconeresis heteropoda, is widely used as a pesticide, targeting pests like caterpillars.
Newton Ashish Shah, Bibek Rajbhandari, Santosh Banstola, Manish Acharya, Rupesh Joshi, Shree Krishna Luitel, Manish Yadav   +6 more
doaj   +2 more sources

Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial. [PDF]

The Lancet, 2023
BACKGROUND Etripamil is a fast-acting, intranasally administered calcium-channel blocker in development for on-demand therapy outside a health-care setting for paroxysmal supraventricular tachycardia.
B. Stambler, A. Camm, M. Alings, P. Dorian, H. Heidbuchel, J. Houtgraaf, P. Kowey, J. Merino, B. Mondésert, J. Piccini, S. Pokorney, P. Sager, A. Verma, J. Wharton, D. Bharucha, F. Plat, S. Shardonofsky, M. Chen, J. Ip, A. Jones, David E. Schleinkofer, S. Winters, Wilson Lam, R. Goldstein, I. Dor, S. Talwar, P. O’Neill, M. Koren, Sean C. Beinart, S. Ambati, S. Mazer, Robert M Kinn, K. Roy, Ramin Manshadi, Richard S Kuk, Aditya Verma, T. Phelan, Alexandru Stoian, K. Ellenbogen, J. Jayachandran, Terence P Connelly, M. Daccarett, Gaurang Gandhi, S. Mittal, A. Abdel-wahab, R. Augostini, J. Ip, Denise Sorrentino, J. Roux, R. Brar, C. Khoo, Matthew Bennett, E. Lo, B. Coutu, L. Sterns, G. Greer, Pradeep Gujja, Robert A Gianfagna, V. Swarup, F. Sogade, S. Wilton, Christopher P. Ruisi, S. Barbera, J. Banchs, V. Korley, Christopher Schulze, R. Damle, J. Healey, A. Pandey, Jeffrey L. Anderson, K. Venkatachalam, P. Noseworthy, Douglas G Friars, Thomas R. Kambur, Evan Lockwood, G. Meininger, Greg Olsovsky, A. Jones, Geral G. Greer, R. Mehta, Saleem Akbar, Malik Salman, B. Rama, Ramesh Arora, D. Shah, Rakesh Shah, M. Cammarata, Andrew Owens, Katherine Ludington, M. Wharton, Mostafa Bagheri, MOHAMMED N. Khan, K. Carr, Sultan M. Siddique, Sunthosh V. Parvathaneni, Subodh R Devabhaktuni, A. Mouhaffel, G. Mark, L. Biase, Sunil Rangappa, Jared Morton, H. Yarmohammadi, Aminul Karim, Aldo Martinez Fleites, T. Nero, Qaiser Shafiq, S. Pandey, Y. Khaykin, J. Joza, G. Gosselin, A. Skanes, J. Vyselaar, Dan Savard, O. Xhaet, E. Catez, J. Vijgen, P. Godart, R. Casado, G. Mairesse, T. Rossenbacker, P. Haemers, E. Hoffer, P. Hausman, A. Vértes, G. Duray, E. Szolnoki, Z. Csanádi, F. Lakatos, Reinhart Dorman, Y. Tuininga, W. Jansen, S. Velthuis, B. V. Bemmel, G. J. Bech, R. Pisters, Suzanne Valk, Tjeerd J. Romer, J. Luermans, D. Beelen, M. Eck, T. Vet, Dirk Shellings, T. Oosterhof, P. Miękus, W. Bebenek, Agata Bielecka-Dąbrowa, J. Gniot, W. Żmuda, M. Kasprzak, Wojciech Balak, P. Ptaszyński, Jacek Nowak, J. Prokopczuk, A. Przybylski, I. Wozniak-Skowerska, P. Derejko, D. Czarnecka, A. Janas, J. Llorens, L. Tercedor, A. I. Romo, R. R. Granell, J. Juanatey, D. Pascual-Figal, M. Martínez‐Sellés, I. A. Camos, A. I. Criado, J. Basterra, Á. Izquierdo, N. R. Gandara, J. A. Colomé, D. P. Diez, Miguel Angel Hervas, M. Medina, J. S. Saint-Gerons, Alonso Leal, I. Lozano, A. Quesada, J. G. Ramos, A. Sarrias, Javier Ramos Maqueda, J. Mansourati, P. Defaye, L. Guédon-Moreau, A. Milhem, M. D. Guillebon, P. Chevalier, M. Badoz, C. Kriatselis, G. Simonis, T. Lewalter, M. Zarse, Andreas Wilke, F. Kraemer, A. Al-Zoebi   +194 more
semanticscholar   +3 more sources

Outcomes Associated With Paroxysmal Supraventricular Tachycardia During Pregnancy

Circulation, 2017
Kuang-Hui Yu, Shue-Fen Luo, Wei-Jan Chen   +2 more
exaly   +2 more sources

Etripamil Nasal Spray for Conversion of Repeated Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia During Long‐Term Follow‐Up: Results From the NODE‐302 Study [PDF]

Journal of the American Heart Association, 2023
, , Francis Plat
exaly   +2 more sources

Paroxysmal supraventricular tachycardias: modern principles of diagnostics and treatment [PDF]

Кардиоваскулярная терапия и профилактика, 2005
The article is devoted to one of the most actual problems in modern arrhythmology - treatment of paroxysmal supraventricular tachycardias. Modern views on diagnostics and treatment of atrio-ventricular (AV) nodal reciprocating tachycardia and AV ...
A. V. Vetluzhsky, I. G. Fomina
doaj   +2 more sources

First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301)

Circulation: Arrhythmia and Electrophysiology, 2022
Background: Pharmacologic termination of paroxysmal supraventricular tachycardia (PSVT) often requires medically supervised intervention. Intranasal etripamil, is an investigational fast-acting, nondihydropyridine, L-type calcium channel blocker ...
B. Stambler, F. Plat, P. Sager, S. Shardonofsky, D. Wight, D. Potvin, A. Pandey, J. Ip, B. Coutu, B. Mondésert, L. Sterns, M. Bennett, Jeffrey L. Anderson, R. Damle, R. Haberman, A. Camm   +15 more
semanticscholar   +1 more source

An Ayurvedic Management of Paroxysmal Supraventricular Tachycardia [PDF]

, 2022
Background: Paroxysmal Supraventricular Tachycardia is a type of Supraventricular tachycardia (SVT) and is defined as intermittent SVT and typically presents with a ventricular rhythm of 160 bpm.
Kumbhar, Prakash, Kore, Naresh, Chouvan, Smita   +2 more
core   +2 more sources